8052307 |
Phosphatidylinositol-3-OH kinase as a direct target of Ras
Fry, MJ,
Gout, I,
Downward, J,
Dhand, R,
Waterfield, MD,
Warne, PH,
Rodriguez-Viciana, P,
Vanhaesebroeck, B
|
Nature |
1994 |
24897931 |
PI3K/AKT signaling pathway and cancer: an updated review
De Santis, MC,
Martini, M,
Braccini, L,
Hirsch, E,
Gulluni, F
|
Ann. Med. |
2014 |
12121613 |
Activation of phosphoinositide 3-kinase gamma by Ras
Suire, S,
Hawkins, P,
Stephens, L
|
Curr. Biol. |
2002 |
21779505 |
Therapeutic strategies for targeting ras proteins
McCormick, F,
Salt, M,
Young, A,
Gysin, S
|
Genes Cancer |
2011 |
1716764 |
Association of p21ras with phosphatidylinositol 3-kinase
Sjölander, A,
Yamamoto, K,
Lapetina, EG,
Huber, BE
|
Proc. Natl. Acad. Sci. U.S.A. |
1991 |
21779497 |
RAS Interaction with PI3K: More Than Just Another Effector Pathway
Downward, J,
Castellano, E
|
Genes Cancer |
2011 |
26085527 |
The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas
Nussinov, R,
Jang, H,
Keskin, O,
Tsai, CJ,
Muratcioglu, S,
Gursoy, A
|
Mol. Cancer Res. |
2015 |
31135801 |
The structural basis for Ras activation of PI3Kα lipid kinase
Nussinov, R,
Zhang, M,
Jang, H
|
Phys Chem Chem Phys |
2019 |
17998941 |
Oncogenic signaling of class I PI3K isoforms
Vogt, PK,
Kang, S,
Denley, A,
Karst, U
|
Oncogene |
2008 |
8665852 |
Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation
Downward, J,
Waterfield, MD,
Warne, PH,
Rodriguez-Viciana, P,
Vanhaesebroeck, B
|
EMBO J. |
1996 |
12094235 |
The phosphatidylinositol 3-Kinase AKT pathway in human cancer
Vivanco, I,
Sawyers, CL
|
Nat. Rev. Cancer |
2002 |
11136978 |
Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma
Suire, S,
Davis, CT,
Walker, EH,
Pacold, ME,
Hawkins, PT,
Stephens, L,
Williams, RL,
Lara-Gonzalez, S,
Eccleston, JF,
Perisic, O
|
Cell |
2000 |